Budding epithelial morphogenesis driven by cell-matrix versus cell-cell adhesion: Cell
Single-cell RNA sequencing data has been deposited in GEO: GSE159780 . All other source data and raw data that support [...]
Effective patient-first approach in rare disease relies on true sales—not channel stocking
Channel stocking is a common practice in which pharmaceutical executives opt to sell a sizable unit amount of a drug [...]
Signs of Health ‘Equity’s’ Chilling Effect on Dissent
The national movement to eradicate what activists call systemic racism and white privilege from medicine and health care has few [...]
HealthVerity Highlights Identity Component of RWD IPGE Platform
The HealthVerity Identity, Privacy, Governance, and Exchange (IPGE) platform recognizes identity as an integral component of its real world data [...]
Big Pharma makes historic earnings by increasing drug prices during a pandemic
Pharmaceutical firms are unveiling their Q2 earnings right now, and America’s largest drug manufacturers are flexing their muscles. Drug giants [...]
Managed Entry Agreements Could Bring Affordability to Multibillion-Dollar Novel Gene Therapy Market
Cogentia’s Senior Analyst Mark Orchard discusses how managed entry agreements (MEAs) could become a major trend in improving access to [...]
Bristol Myers Squibb Senior VP Discusses Career Journey, Leadership Style, and Improving Access to Drugs Globally
Ester Banque, senior vice president and head of Intercontinental Commercial at Bristol Myers Squibb, discusses her career path and evolving [...]
ISMPP Welcomes Abstracts for 2022 European Meeting
The International Society for Medical Publication Professionals (ISMPP) will hold its 2022 European Meeting on January 25th and 26th in [...]
Aetion Updates FDA Decision Alerts Database Following FDA’s Accelerated Approval of Oncology Drug LUMAKRAS
LUMAKRAS (sotarasib) was received accelerated approval from the Food and Drug Administration (FDA). The use of real world evidence (RWE) [...]
New Article Details $93.3 Billion Annual Costs in Drug Utilization Management
An article published in Health Affairs details the multibillion-dollar costs associated with inflated drug utilization management. The estimated $93.3 billion [...]
Aetion Adds Rabies Drug to FDA Decision Alerts Library Following Pediatric RWE Study
The Food and Drug Administration’s Center for Biologics Evaluation and Research has issued approval for a supplemental Biologics License Application [...]
ICER President Discusses How Iffy Biogen Decision May Bring Down FDA’s Accelerated Approval Program
Steve Pearson of the Institute for Clinical and Economic Review (ICER) weighed in on how the Food and Drug Administration’s [...]
MMIT’s AIS Health Article Details Efficacy and Costs of Specialty Drugs
MMIT’s AIS Health recently published an article on specialty pharmacy. Employers are typically resistant to drugs commanding high price tags. [...]
Pfizer and BioNTech Raise Price of COVID-19 Vaccine as UK Orders Booster Shots, Pfizer’s 2021 Sales Hit $11.3 Billion
Pfizer and BioNTech announced a price increase for COVID-19 booster shots—from £18 to £22. The European Union and the United [...]
Novartis and University of California-Berkeley Researchers Estimate $93 Billion Wasted Yearly Across Healthcare Stakeholders, Propose Value-Based Pricing System
Researchers at the University of California-Berkeley and Novartis note that $93 billion is wasted yearly in addressing healthcare utilization management, [...]
CORRECTING and Replacing – GoodRx and Boehringer Ingelheim Announce Joint Effort to Deliver Affordability Solutions to Patients
Potential to provide approximately $15 million a year in savings for life-enhancing medications SANTA MONICA, Calif., Aug. 09, 2021 (GLOBE [...]
AbbVie HEOR Expert Notes Lack of Diversity Negatively Impacts Clinical Trials, RWD Offers Possible Solution
Vice President and Global Head of Health Economics and Outcomes Research (HEOR) at AbbVie Dr. Chris Boone notes that the [...]
Department of Veterans Affairs Rejects Biogen’s Aduhelm, PBM Criticizes Controversial Drug
The Department of Veterans Affairs (VA) has rejected Biogen’s expensive Aduhelm for use in Alzheimer’s disease. The VA is the [...]
NAMCP’s Product Value Proposition Customer Engagement Short Form Improves Efficiency Among Decision Makers
The National Association of Managed Care Physicians (NAMCP) is offering a short form intended to improve efficiency and efficacy among [...]
Researchers Evaluate Oncology Treatment Costs at the National Cancer Institute and Community Hospitals
Researchers evaluated costs associated with cancer treatment in community hospitals and at the National Cancer Insitute (NCI), noting variation in [...]
PHAR President and Health Economics Director Discuss the Inherent Racism in Cost-Effectiveness Analyses
PHAR President and Founder Dr. Michael Broder and Director of Health Economics Jesse Ortendahl shared their thoughts on how cost-effectiveness [...]
Part 1 of the ISMPP’s InformED Podcast Series on the Changing Medical Conference Landscape Now Available
The first part of the InformED podcast series offered by the International Society for Medical Publication Professionals (ISMPP) is now [...]
[JAMA Article] Doctors Unwillingly Promoted to Bill Collectors as Healthcare Affordability Concerns Persist
High healthcare costs in the United States are impacting all facets of the industry. A recent article, published in JAMA, [...]
ISPOR Article Evaluates Bias Assessment Tools in HEOR
An article published in ISPOR’s Value in Health journal discusses bias assessment tools. The authors distinguish between absolute and relative [...]
Register Today for IQVIA’s Tuesday Webinar on Surrogate Endpoints in Oncology Clinical Trials
The IQVIA Institute for Human Data Science will host a webinar at 10:00 AM EDT on Tuesday, August 17th on [...]